Seoul Pharma Co., Ltd (KOSDAQ:018680)
South Korea · Delayed Price · Currency is KRW 1,938.00
-1.00 (-0.05%)
At close: Oct 2, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 22.6 billion as of October 2, 2026. Its market cap has decreased by -38.77% in one year.
Market Cap
22.60B
Enterprise Value
20.83B
Revenue
51.08B
Ranking
n/a
PE Ratio
12.99
Stock Price
1,938.00
ChartMarket Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 22.60B, an increase of 12.98%. That is a compound annual growth rate of 0.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 22.60B | -37.08% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 34.64B |
| Pharmsville | 27.10B |
| HLscience | 26.53B |
| Baskhanbio Pharma | 24.53B |
| Daesung Microbiological Labs. | 23.03B |
| BIFIDO | 21.43B |
| Hurum | 20.44B |
| Union Korea Pharm | 19.70B |